Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ampio Pharmaceuticals Inc

+ Add to Watchlist

AMPE:US

5.6400 USD 0.0200 0.35%

As of 20:04:04 ET on 02/27/2015.

Snapshot for Ampio Pharmaceuticals Inc (AMPE)

Open: 5.6400 Day's Range: 5.4500 - 5.7500 Volume: 425,046
Previous Close: 5.6600 52wk Range: 3.1900 - 8.6700 1-Yr Rtn: -20.79%

Stock Chart for AMPE

No chart data available.
  • AMPE:US 5.6400
  • 1D
  • 1M
  • 1Y
5.6600
Interactive AMPE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMPE

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8100
Est. EPS (USD) (12/2015) -0.6150
Est. PEG Ratio -
Market Cap (M USD) 293.12
Shares Outstanding (M) 51.97
30 Day Average Volume 784,315
Price/Book (mrq) 4.4333
Price/Sale (ttm) 4,083.2391
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMPE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMPE

Ampio Pharmaceuticals, Inc. researches and develops drugs. The Company researches treatments for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The Company's product pipeline includes some new uses for previously approved drugs.

Michael Macaluso JrChairman/CEOGregory A GouldCFO/Treasurer/Secretary
Joshua R Disbrow "Josh"Chief Operating OfficerDavid Bar-OrChief Scientific Officer
More Company Profile & Key Executives for AMPE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil